{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T22:54:26Z","timestamp":1777416866798,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s00108-016-0171-2","type":"journal-article","created":{"date-parts":[[2017,1,10]],"date-time":"2017-01-10T07:27:55Z","timestamp":1484033275000},"page":"47-58","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Autoimmune Schilddr\u00fcsenerkrankungen","Autoimmune diseases of the thyroid gland"],"prefix":"10.1007","volume":"58","author":[{"given":"S.","family":"Allelein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Feldkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Schott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,10]]},"reference":[{"issue":"Suppl","key":"171_CR1","first-page":"252","volume":"42","author":"DS Mc Leod","year":"2012","unstructured":"Mc Leod DS, Cooper DS (2012) The incidence and prevalence of thyroid autoimmunity. Endocrine 42(Suppl):252\u2013265","journal-title":"Endocrine"},{"issue":"7","key":"171_CR2","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1089\/thy.2011.0525","volume":"22","author":"H V\u00f6lzke","year":"2012","unstructured":"V\u00f6lzke H, Ittermann T, Albers M, Friedrich N, Nauck M, Below H, Kramer A (2012) Five-year change in morphological and functional alterations oft he thyroid gland: the Study of Health in Pomerania. Thyroid 22(7):737\u2013746","journal-title":"Thyroid"},{"issue":"2","key":"171_CR3","first-page":"303","volume":"18","author":"A Stagnaro-Green","year":"2011","unstructured":"Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R, Nixon A, Pearce EN, Soldin OP, Sullivan S, Wiersinga W (2011) Postpartum thyroiditis Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and rostpartum. Thyroid 18(2):303\u2013316","journal-title":"Thyroid"},{"issue":"4","key":"171_CR4","first-page":"232","volume":"48","author":"S Barkia Beradhi","year":"2016","unstructured":"Barkia Beradhi S, Flesch BK, Hansen MP, Matheis N, Kahaly GJ (2016) HLA class II differentiates between thyroid and polyglandular autoimmunity. Horm Metab Res 48(4):232\u2013237","journal-title":"Horm Metab Res"},{"key":"171_CR5","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1172\/JCI78088","volume":"125","author":"MD Rosenblum","year":"2015","unstructured":"Rosenblum MD, Remedios KA, Abbas AK (2015) Mechanisms of human autoimmunity. J\u00a0Clin Invest 125:2228\u20132233","journal-title":"J Clin Invest"},{"issue":"6","key":"171_CR6","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1055\/s-0029-1215568","volume":"41","author":"ML Tanda","year":"2009","unstructured":"Tanda ML, Piantanida E, Lai A, Lombardi V, Dalle Mule I, Liparulo L, Pariani N, Bartalena L (2009) Thyroid autoimmunity and environment. Horm Metab Res 41(6):436\u2013442. doi: 10.1055\/s-0029-1215568","journal-title":"Horm Metab Res"},{"key":"171_CR7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1530\/EJE-15-0028","volume":"173","author":"V Cirello","year":"2015","unstructured":"Cirello V, Rizzo R, Crippa M, Campi I, Bortolotti D, Bolzani S, Colombo C, Vannucchi G, Maffini MA, de Liso F, Ferrero S, Finelli P, Fugazzola L (2015) Fetal cell microchimerism: a\u00a0protective role in autoimmune thyroid diseases. Eur J Endocrinol Thyroid 173:111\u2013118","journal-title":"Eur J Endocrinol Thyroid"},{"issue":"4","key":"171_CR8","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1210\/jc.2011-2178","volume":"97","author":"M Ehlers","year":"2012","unstructured":"Ehlers M, Thiel A, Bernecker C, Porwol D, Papewalis C, Willenberg HS, Schinner S, Hautzel H, Scherbaum WA, Schott M (2012) Evidence of a\u00a0combined cytotoxic thyroglobulin and thyroperoxidase epitope-specific cellular immunity in Hashimoto\u2019s thyroiditis. J Clin Endocrinol Metab 97(4):1347\u20131354","journal-title":"J Clin Endocrinol Metab"},{"key":"171_CR9","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1055\/s-0035-1548832","volume":"47","author":"RA Ajjan","year":"2015","unstructured":"Ajjan RA, Weetman AP (2015) The pathogenesis of Hashimoto\u2019s thyreoiditis: further developments in our understanding. Horm Metab Res 47:702\u2013710","journal-title":"Horm Metab Res"},{"key":"171_CR10","doi-asserted-by":"crossref","unstructured":"Schott M (2013) Hyperthyreose. Internist 54:315\u2013327","DOI":"10.1007\/s00108-012-3196-1"},{"key":"171_CR11","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1055\/s-0042-112815","volume":"48","author":"M Ehlers","year":"2016","unstructured":"Ehlers M, Jordan AL, Feldkamp J, Fritzen R, Quadbeck B, Haase M, Allelein S, Schmied C, Schott M (2016) Anti-thyroperoxidase antibody levels \u3009500 IU\/ml indicate a\u00a0moderately increased risk for developing hypothyroidism in autoimmune thyroiditis. Horm Metab Res 48:623. doi: 10.1055\/s-0042-112815","journal-title":"Horm Metab Res"},{"issue":"1","key":"171_CR12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2265.1995.tb01894.x","volume":"43","author":"MP Vanderpump","year":"1995","unstructured":"Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F et al (1995) The incidence of thyroid disorders in the community: a\u00a0twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 43(1):55\u201368","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"171_CR13","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1210\/jc.2011-2803","volume":"97","author":"L Groot De","year":"2012","unstructured":"De Groot L, Abalovich M, Alexander EK, Amino N, Barbour L, Cobin RH, Eastman CJ, Lazarus JH, Luton D, Mandel SJ, Mestman J, Rovet J, Sullivan S (2012) Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J\u00a0Clin Endocrinol Metab 97(8):2543\u20132565","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"171_CR14","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1055\/s-0035-1559631","volume":"47","author":"LH Duntas","year":"2015","unstructured":"Duntas LH (2015) The role of iodine and selenium in autoimmune thyroiditis. Horm Metab Res 47(10):721\u2013726. doi: 10.1055\/s-0035-1559631","journal-title":"Horm Metab Res"},{"issue":"3","key":"171_CR15","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/cen.12284","volume":"80","author":"SA Eskes","year":"2014","unstructured":"Eskes SA, Endert E, Fliers E, Birnie E, Hollenbach B, Schomburg L, K\u00f6hrle J, Wiersinga WM (2014) Selenite supplementation in euthyroid subjects with thyroid peroxidase antibodies. Clin Endocrinol (Oxf) 80(3):444\u2013451","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"Suppl 1","key":"171_CR16","first-page":"114","volume":"59","author":"AP Weetman","year":"2003","unstructured":"Weetman AP (2003) Grave\u2019s disease 1835\u20132002. Horm Res 59(Suppl 1):114\u2013118","journal-title":"Horm Res"},{"issue":"10","key":"171_CR17","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1055\/s-0035-1559646","volume":"47","author":"R Pujol-Borrell","year":"2015","unstructured":"Pujol-Borrell R, Gimenez-Barcons M, Marin-Sanchez A, Colobran R (2015) Genetics of graves\u2019 disease: special focus on the role of TSHR gene. Horm Metab Res 47(10):753\u2013766. doi: 10.1055\/s-0035-1559646","journal-title":"Horm Metab Res"},{"issue":"5","key":"171_CR18","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1210\/jc.2016-1220","volume":"101","author":"GJ Kahaly","year":"2016","unstructured":"Kahaly GJ, Diana T, Glang J, Kanitz M, Pitz S, K\u00f6nig J (2016) Thyroid stimulating antibodies are highly prevalent in Hashimoto\u2019s thyreoiditis and associated orbitopathy. J\u00a0Clin Endocrinol Metab 101(5):1998\u20132004. doi: 10.1210\/jc.2016-1220","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"171_CR19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1055\/s-2007-978666","volume":"32","author":"M Schott","year":"2000","unstructured":"Schott M, Feldkamp J, Bathan C, Fritzen R, Scherbaum WA, Seissler J (2000) Detecting TSH-receptor antibodies with the recombinant TBII assay: technical and clinical evaluation. Horm Metab Res 32(10):429\u2013435","journal-title":"Horm Metab Res"},{"issue":"12","key":"171_CR20","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1055\/s-0035-1554662","volume":"47","author":"CU Frank","year":"2015","unstructured":"Frank CU, Braeth S, Dietrich JW, Wanjura D, Loos U (2015) Bridge technology with TSH receptor chimera for sensitive direct detection of TSH receptor antibodies causing graves\u2019 disease: analytical and clinical evaluation. Horm Metab Res 47(12):880\u2013888","journal-title":"Horm Metab Res"},{"issue":"12","key":"171_CR21","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1055\/s-2005-921102","volume":"37","author":"B Quadbeck","year":"2005","unstructured":"Quadbeck B, Hoermann R, Hahn S, Roggenbuck U, Mann K, Janssen OE (2005a) Binding, stimulating and blocking TSH receptor antibodies to the thyrotropin receptor as predictors of relapse of Graves\u2019 disease after withdrawal of antithyroid treatment. Horm Metab Res 37(12):745\u2013750","journal-title":"Horm Metab Res"},{"issue":"3","key":"171_CR22","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1089\/thy.2006.16.295","volume":"16","author":"C Carella","year":"2006","unstructured":"Carella C, Mazziotti G, Sorvillo F, Piscopo M, Cioffi M, Pilla P, Nersita R, Iorio S, Amato G, Braverman LE, Roti E (2006) Serum thyrotropin receptor antibodies concentrations in patients with Graves\u2019 disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and\/or thyroid response modify during the observation period. Thyroid 16(3):295\u2013302","journal-title":"Thyroid"},{"issue":"5","key":"171_CR23","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00063-009-1072-0","volume":"104","author":"A Eckstein","year":"2009","unstructured":"Eckstein A, Mann K, Kahaly GJ, Grussendorf M, Reiners C, Feldkamp J, Quadbeck B, Bockisch A, Schott M (2009) Role of TSH receptor autoantibodies for the diagnosis of Graves\u2019 disease and for the prediction of the course of hyperthyroidism and ophthalmopathy. Recommendations of the Thyroid Section of the German Society of Endocrinology. Med Klin (Munich) 104(5):343\u2013348","journal-title":"Med Klin (Munich)"},{"issue":"2","key":"171_CR24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1055\/s-2004-814217","volume":"36","author":"M Schott","year":"2004","unstructured":"Schott M, Morgenthaler NG, Fritzen R, Feldkamp J, Willenberg HS, Scherbaum WA, Seissler J (2004) Levels of autoantibodies against human TSH receptor predict relapse of hyperthyroidism in Graves\u2019 disease. Horm Metab Res 36(2):92\u201396","journal-title":"Horm Metab Res"},{"issue":"11","key":"171_CR25","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s40618-014-0136-z","volume":"37","author":"M Marino","year":"2014","unstructured":"Marino M, Latrofa F, Menconi F, Chiovato L, Vitti P (2014) An update on the medical treatment of Graves\u2019 hyperthyroidism. J\u00a0Endocrinol Invest 37(11):1041\u20131048","journal-title":"J Endocrinol Invest"},{"issue":"9","key":"171_CR26","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1210\/jc.2005-2813","volume":"91","author":"AK Eckstein","year":"2006","unstructured":"Eckstein AK, Plicht M, Lax H, Neuhauser M, Mann K, Lederbogen S, Heckmann C, Esser J, Morgenthaler NG (2006) Thyrotropin receptor autoantibodies are independent risk factors for Graves\u2019 ophthalmopathy and help to predict severity and outcome of the disease. J\u00a0Clin Endocrinol Metab 91(9):3464\u20133470","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"171_CR27","doi-asserted-by":"crossref","first-page":"657","DOI":"10.7326\/0003-4819-146-9-200705010-00009","volume":"146","author":"F Andersohn","year":"2007","unstructured":"Andersohn F, Konzen C, Garbe E (2007) Systematic review: agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med 146(9):657\u2013665","journal-title":"Ann Intern Med"},{"issue":"3","key":"171_CR28","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/bcp.12336","volume":"78","author":"MT Wang","year":"2014","unstructured":"Wang MT, Lee WJ, Huang TY, Chu CL, Hsieh CH (2014) Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: a\u00a0population-based cohort study. Br J Clin Pharmacol 78(3):619\u2013629","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"171_CR29","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1055\/s-0035-1555759","volume":"47","author":"E Piantanida","year":"2015","unstructured":"Piantanida E, Lai A, Sassi L, Gallo D, Spreafico E, Tanda ML, Bartalena L (2015) Outcome prediction of treatment of graves\u2019 hyperthyroidism with antithyroid drugs. Horm Metab Res 47(10):767\u2013772","journal-title":"Horm Metab Res"},{"issue":"6","key":"171_CR30","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1111\/cen.12949","volume":"84","author":"O Isozaki","year":"2016","unstructured":"Isozaki O, Satoh T, Wakino S, Suzuki A, Iburi T, Tsuboi K, Kanamoto N, Otani H, Furukawa Y, Teramukai S, Akamizu T (2016) Treatment and management of thyroid storm: analysis of the nationwide surveys: The taskforce committee of the Japan Thyroid Association and Japan Endocrine Society for the establishment of diagnostic criteria and nationwide surveys for thyroid storm. Clin Endocrinol (Oxf) 84(6):912. doi: 10.1111\/cen.12949","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"42","key":"171_CR31","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1055\/s-0034-1387300","volume":"139","author":"D F\u00fchrer","year":"2014","unstructured":"F\u00fchrer D, Mann K, Feldkamp J, Krude H, Spitzweg C, Kratzsch J, Schott M (2014) Schilddr\u00fcsenfunktionsst\u00f6rungen in der Schwangerschaft. Dtsch Med Wochenschr 139(42):2148\u20132152","journal-title":"Dtsch Med Wochenschr"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-016-0171-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-016-0171-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-016-0171-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T03:48:03Z","timestamp":1498362483000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-016-0171-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["171"],"URL":"https:\/\/doi.org\/10.1007\/s00108-016-0171-2","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}